←
ERS Assembly 12 - ILD173 posts
ERS Assembly 12 - ILD avatar

ERS Assembly 12 - ILD

@ers_ild

Official ERS Assembly 12 - Interstitial Lung Disease - Twitter account. Managed by the Assembly officers.

◷ Joined September 2021▧ 38 Photos and videos
NEJM avatar
⟳ ERS Assembly 12 - ILD retweeted
NEJM@NEJM·18 May 2025

Presented at #ATS2025: In the PREDMETH trial, first-line treatment of pulmonary sarcoidosis with methotrexate was noninferior to that with prednisone regarding the change at 24 weeks in the percentage of the predicted forced vital capacity. Full trial results: nej.md/4kdaf0o Editorial: Methotrexate as Initial Therapy for Symptomatic Pulmonary Sarcoidosis? nej.md/4mhaHfW @atscommunity

Post attachment
Malik A. Althobiani | مالك avatar
⟳ ERS Assembly 12 - ILD retweeted
Malik A. Althobiani | مالك@DrMal1k·14 Mar 2025

سعدت بالمشاركة🇸🇦 في كتابة هذه الورقة مع نخبة من الباحثين المتميزين من هولندا، ألمانيا، بريطانيا، وإيطاليا، والمنشور في ERJ Open Research. @KarenMoor2 @Istamina Our latest article has been published in ERJ Open Research! It was a pleasure to work with Dr Laura, Karen, Prof. Marlies Wijsenbeek, and Michael Kreuter. pmc.ncbi.nlm.nih.gov/article…

Post attachment
ERS Assembly 12 - ILD avatar
ERS Assembly 12 - ILD@ers_ild·17 Jan 2025

🚨 Only 2 weeks left to apply for the ECM Mentoring Programme! 🚨 If you applied before Jan 15, please resubmit your application to ensure it's received. Don't miss this opportunity—apply now!

🌟 Excited to grow your career? The ERS Assembly 12 Mentoring Programme is launching! 💡 Gain insights, set goals, and connect with mentors & peers through 5 interactive sessions (virtual + onsite at #ERS2025). ⏳ Apply by Jan 31, 2025: forms.office.com/e/kCNNRetdD… #Mentorship #ERS

Prof Chris Scotton avatar
⟳ ERS Assembly 12 - ILD retweeted
Prof Chris Scotton@Isteefer·16 Sep 2024

Cannot wait to see the data from the FIBRONEER Phase III trial of nerandomilast in IPF! This is a very exciting development on the back of all the earlier Phase II study results... And a very timely announcement in the middle of PF awareness month!

#NEWS: We’re excited to announce that our Phase III trial in people living with idiopathic pulmonary fibrosis (IPF) met its primary endpoint.     Learn more here: bit.ly/47JWDoB

Post attachment
Laura Fabbri avatar
⟳ ERS Assembly 12 - ILD retweeted
Laura Fabbri@Istamina·9 Sep 2024

I hope you enjoyed meeting us! Please fill out the form above and keep your competencies list up to date on Myers' profile.

Post attachment